Keep them, but at a fraction of their value. The trick is to get relisted. I am sure if ASX talks to ANZ the commercially correct decision will be made.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025